Award recordCONTRACT

CORGENIX MEDICAL CORPORATION

PIID VA25917J4606· VHA· NETWORK CONTRACT OFFICE 19 (36C259)· 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS· FY2017· $17,040 net obligations· UEI LL3JF6BUDL58· CO

Description

IGF::OT::IGF ANTI-CARDIOLIPIN 2-PLATE TEST KITS FOR IGG AND IGM TESTING AT ECHCS

First action · last action
2017-04-27 · 2017-04-27
Transactions
1
First transaction's obligation
$17,040
Base + all options value (sum of deltas)
$17,040
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
SMALL BUSINESS SET ASIDE - TOTAL
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA25914A0174
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

Modification chain · 1 transaction

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$17,040$0Base award · 2017-04-27 · this action $17,040 · running total $17,040
  • Base2017-04-27+$17,040= $17,040
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2017-04-27+$17,040$17,040IGF::OT::IGF ANTI-CARDIOLIPIN 2-PLATE TEST KITS FOR IGG AND IGM TESTING AT ECHCS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI LL3JF6BUDL58)

AwardOffice · PSC / listingNet obligationsFY
36C25918N2695NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$7,100FY2018
VA25916J0001NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$13,103FY2016
VA25915J5974259-NETWORK CONTRACT OFFICE 19 · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$12,785FY2015
VA25914A0174259-NETWORK CONTRACT OFFICE 19 · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$0FY2014
VA25914J4173259-NETWORK CONTRACT OFFICE 19 · Q301 · MEDICAL- LABORATORY TESTING$16,102FY2014
VA25914D0347259-NETWORK CONTRACT OFFICE 19 · Q301 · MEDICAL- LABORATORY TESTING$0FY2014

Other recipients under 6550 from NETWORK CONTRACT OFFICE 19 (36C259) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25926N0457BECTON, DICKINSON AND COMPANYNETWORK CONTRACT OFFICE 19 (36C259)$147,256FY2026
36C25926N0353QIAGEN, LLCNETWORK CONTRACT OFFICE 19 (36C259)$88,310FY2026
36C25926N0292FISHER SCIENTIFIC COMPANY L.L.C.NETWORK CONTRACT OFFICE 19 (36C259)$165,000FY2026
36C25926N0280ALBA BIOSCIENCE, INC.NETWORK CONTRACT OFFICE 19 (36C259)$64,078FY2026
36C25926N0316POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLCNETWORK CONTRACT OFFICE 19 (36C259)$50,343FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25917J4606_3600_VA25914A0174_3600 · retrieved 2026-09-26.